Remote New

Director, LDT & Diagnostics Enablement

Quanterix
tuition assistance, 401(k)
United States
Jun 17, 2026
Director, LDT & Diagnostics Enablement United States - Remote Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company, adding multiplexed tissue imaging with single-cell resolution to its portfolio. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue-advancing precision medicine from discovery to diagnostics. ROLE SUMMARY: Quanterix is seeking a Director, LDT & Diagnostics Enablement to accelerate adoption of clinical biomarker technologies across the U.S. laboratory-developed test (LDT) market, with a specific focus on CLIA-certified laboratories developing, validating, or commercializing LDTs in liquid biopsy and tissue biopsy applications. This is a senior, external-facing market development role responsible for creating access, generating qualified strategic engagement, and building relationships with organizations developing biomarker-based LDTs. The ideal candidate will bring deep familiarity with the U.S. LDT ecosystem, diagnostic laboratory decision-making, biomarker commercialization, and the needs of organizations translating biomarker science into diagnostic testing. This individual must be comfortable selling and positioning a complete laboratory solution, including capital equipment, reagents, consumables, Accelerator sample testing services, and custom assay development services. The role will identify, qualify, and transition opportunities to the appropriate local Business Development Manager, Strategic Account Manager, Accelerator, or technical team. WHAT YOU'LL DO: Build and maintain a prioritized universe of U.S.-based CLIA-certified laboratories, including CAP-accredited and other accredited diagnostic laboratory organizations, actively developing, validating, or commercializing LDTs Identify companies and diagnostic laboratory organizations working in liquid biopsy, tissue biopsy, spatial biology, proteomics, ultrasensitive biomarker detection, companion diagnostic development, translational medicine, and diagnostic assay development where Quanterix capabilities may provide strategic value Develop segmentation of target accounts based on diagnostic application, biomarker focus, LDT development stage, commercial readiness, strategic fit, workflow fit, and near-term revenue potential Secure introductory and strategic meetings with decision-makers at CLIA-certified labs, diagnostics companies, biotech organizations, pharma-adjacent diagnostic developers, commercial testing organizations, and translational biomarker companies Engage senior scientific, diagnostic, laboratory, commercial, operational, and executive stakeholders, including Laboratory Directors, Medical Directors, Heads of Diagnostic Development, Translational Medicine leaders, Commercial Diagnostics leaders, Operations leaders, and Business Development executives Position Quanterix's full portfolio to LDT developers, including capital equipment, reagents, consumables, sample testing services, and custom assay development Develop and advance opportunities involving capital equipment placement, platform adoption, lab workflow integration, and long-term reagent and consumable pull-through Position Accelerator services as a strategic entry point for customers who need sample testing, feasibility work, proof-of-concept studies, biomarker validation support, or custom assay development before broader platform adoption Help customers understand when to start with services, when to transition to platform ownership, and how Quanterix can support longer-term assay development and diagnostic testing objectives BASIC QUALIFICATIONS: Bachelor's degree in life sciences, biochemistry, biotechnology, diagnostics, business, or a related field; advanced degree preferred 10+ years of commercial, business development, strategic account manager, market development, or sales experience in life sciences, diagnostics, diagnostic laboratory services, translational medicine, biomarker testing, oncology diagnostics, proteomics, spatial biology, or related markets Minimum of 2 years of direct experience working with, selling to, or partnering with organizations developing or commercializing LDTs in the United States PREFERRED QUALIFICATIONS: Existing network within U.S.-based CLIA-certified laboratories, diagnostics companies, oncology testing companies, molecular diagnostics organizations, reference labs, or translational biomarker developers Experience supporting commercialization of biomarker-based assays, diagnostic tests, diagnostic platforms, or laboratory-developed tests Experience selling both upfront platform placements and recurring revenue models, including reagents, consumables, assays, services, or testing programs Familiarity with CLIA-regulated and CAP-accredited laboratory environments, including analytical validation, diagnostic validation, quality systems, sample handling, and workflow requirements for LDT development Familiarity with RUO-to-diagnostic translation, LDT validation, analytical validation, diagnostic validation, diagnostic utility, payer evidence, and commercial launch considerations Experience or working knowledge related to FDA, IVD, NYS CLEP, regulatory submission strategy, or interactions with regulatory affairs teams preferred but not required Prior experience in a senior market development, strategic business development, strategic account, or new-market creation role Demonstrated experience selling into or engaging with CLIA-certified laboratories, commercial diagnostic labs, diagnostics developers, or organizations involved in diagnostic assay validation and commercialization Experience selling or positioning complex life science or diagnostics solutions that may include capital equipment, reagents, consumables, service-based offerings, assay development, or sample testing services Proven ability to open doors, create access, develop new relationships, and generate qualified commercial opportunities in complex scientific markets EXPECTATIONS, COMPETENCIES, SKILLS & ABILITIES: Workplace location: Remote, United States. Candidate should be located near a major airport with access to key U.S. diagnostic laboratory, diagnostics, pharma, biotech, and translational medicine markets Travel expectation: Approximately 40%-60% for customer meetings, conferences, strategic account visits, field collaboration, and internal business reviews This role is not responsible for final quoting, pricing, negotiation, or closing sales. Opportunities will be transitioned to the appropriate local BDM, SAM, Accelerator, or technical commercial owner for execution Ability to engage credibly with scientific, diagnostic, laboratory, commercial, operational, and executive stakeholders Strong understanding of the U.S. LDT ecosystem, including laboratory decision-making, assay development workflows, validation requirements, diagnostic evidence generation, sample handling, workflow implementation, and commercialization pathways Strong CRM discipline and ability to translate early-stage market activity into structured pipeline development Excellent communication, executive presence, business judgment, and cross-functional collaboration skills Ability to operate independently in a newly created role while building alignment across Sales, Marketing, Product, Accelerator, Scientific Affairs, and Executive Leadership Must be able to lift up to 20 pounds occasionally for travel, conference, and customer meeting-related materials WHY YOU'LL LIKE WORKING WITH US: Our Technology: From discovery to diagnostics, Quanterix's ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. Simoa technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Our industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease. Akoya Biosciences, a Quanterix company, is The Spatial Biology Company-bringing tissue context to life through high-resolution, single-cell imaging. Akoya's spatial phenotyping platforms help researchers visualize and measure how cells organize and interact within tissue to influence disease progression and therapeutic response. From discovery through diagnostic research, Akoya offers a full continuum of solutions, including PhenoCycler, PhenoImager Fusion and HT, and PhenoCode Panels. As part of Quanterix, Akoya complements a leading portfolio of ultra-sensitive biomarker detection technologies, together enabling a more complete view of biology and disease across both tissue and blood. Our Commitment to Employees: At Quanterix, our values are based on: Team, Innovation, Customer and Owner. Team: Challenge assumptions, not the person. Respect diversity of thought and hold ourselves to lofty standards Innovation: Stay curious, experiment, create and change Customer: Prioritize and celebrate these pioneers by doing our best to deliver on commitments Owner: Act with high integrity and in the best interest of Quanterix. Take measured risks and learn from their success and failures. We reward and recognize our employees by offering competitive compensation and a 401k plan with employer match, as well as competitive health, dental, and vision benefits for employees and their dependents. We also offer an unlimited vacation policy to all exempt employees, and a generous PTO policy for non-exempt employees. All employees are eligible for equity, employee stock purchase plan, a performance bonus, and 1:1 financial counseling/planning. We also offer Tuition Assistance. We have a free, state-of-the-art onsite fitness center for all employees. To keep you fueled up, we provide onsite employees free snacks and drinks every day! DIVERSE & INCLUSIVE WORKPLACE: Quanterix is committed to a Diverse and Inclusive workplace. We strive to recruit candidates who will bring inclusive mindsets and contribute to our values. Quanterix is an Equal Opportunity Employer and does not discriminate based on race, national origin, gender, gender identity, sexual orientation, protected veteran status, disability, age, or other legally protected status. Quanterix will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.